Key result
Refractory angina pectoris is a chronic condition with a variety of medical and interventional treatment options available that require a multidisciplinary approach for optimal management.
Why the study?
Refractory angina pectoris has no cure, prompting a review of the medical and interventional treatment options available in 2021 along with their mechanisms and evidence.
Refractory angina requires a multidisciplinary approach utilizing novel medical, interventional, and neuromodulatory therapies to improve patient quality of life and reduce healthcare burden.
Supports multidisciplinary care for refractory angina; leaves open optimal sequencing of novel therapies.
Refractory Angina Pectoris is a chronic pain condition relating to myocardial ischaemia in the presence of coronary artery disease despite optimal medical therapy. It affects a cohort of patients with a subset of the coronary perfusion deficiencies. While there is no cure for these patients, an array of medical and interventional treatment is available in 2021. In this article we discuss the options available with an explanation of the mechanisms of action and evidence for their use.
No takes yet. Share an insight, caveat, or question.
Valchanov et al. (2021) conducted a review in Refractory Angina Pectoris. Medical and interventional treatments was evaluated. Refractory angina pectoris is a chronic condition with a variety of medical and interventional treatment options available that require a multidisciplinary approach for optimal management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: